T. Vaskonen et al., Development of chronic allograft rejection and arterial hypertension in Brown Norway rats after renal transplantation, BLOOD PRESS, 9(2-3), 2000, pp. 162-168
The cardiovascular and renal pathophysiology associated with chronic renal
allograft rejection under triple drug immunosuppressive treatment was studi
ed using a recently developed model (Brown Norway (BN) rats) in a 6-week ex
periment. Renal transplantation was performed to 10-week-old rats in a rat
strain combination of Dark Agouti (DA) --> BN. The right kidney was removed
from another group of BN rats (uninephrectomized). A triple drug treatment
comprising cyclosporine (10 mg/kg subcutaneously, s.c.), azathioprine (2 m
g/kg s.c.) and methylprednisolone (1.6 mg/kg s.c.) was given to each rat da
ily for 6 weeks. A control group underwent no operations nor drug treatment
. After the transplantation, the systolic blood pressure in this group was
increased from 116 +/- 2 to 166 +/- 2 mmHg, while in the uninephrectomized
group the rise was from 115 +/- 4 to 146 +/- 4 mmHg, and no change was obse
rved in the blood pressures of the control group. The vascular relaxation r
esponses of mesenteric arterial rings in vitro to acetylcholine were inhibi
ted in both the transplantation group and the uninephrectomized group as co
mpared with the control group, but few significant differences were found i
n the contraction responses to noradrenaline and potassium chloride. Graft
histology was examined after 6 weeks, quantified by using the chronic allog
raft damage index (CADI). Changes specific to a chronic rejection reaction
were observed in the allografts (CADI mean 6.0) but no injuries were seen i
n the rats' own kidneys (CADI mean 1.2). Our findings show that allograft r
ejection in BN rats after renal transplantation is associated with the deve
lopment of arterial hypertension. The combination of cyclosporine, methylpr
ednisolone and azathioprine also rises blood pressure in uninephrectomized
BN rats. The hypertensive effects of the drug treatment and graft rejection
are associated with endothelial dysfunction.